TGM2 and cancer: But apart from these well-established markers, other proteins were found to be increased in EMT-undergoing cancer cells or were involved in induction/maintenance of mesenchymal features of cancer cells; these include: EGFR [21, 22], MCAM [23, 24], MUC1 [25], PI3K [26–28], AKT2 [28, 29], BIRC5 [28, 30], HER2 [31], HER3 [32], TG2 [33, 34], FOXC2 [35, 36], MAGEA3 [37], AURKA [38, 39], MGB1 [40], PLS-3 [41].